Estimating the lifelong health impact and financial burdens of different types of lung cancer

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Yang, Szu Chun ^a   Lai, Wu Wei ^a   Su, Wu Chou ^a   Wu, Shang Yin ^a   Chen, Helen H W ^a   Wu, Yi Lin ^a   Hung, Mei Chuan ^a   Wang, Jung Der ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Costs; Life expectancy; Lung cancer prevention; Out of pocket money; Quality adjusted life expectancy

Indexed keywords

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EUROQOL 5 DIMENSION; FEMALE; HEALTH CARE COST; HUMAN; LIFE EXPECTANCY; LOSS OF QUALITY ADJUSTED LIFE EXPECTANCY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; NATIONAL HEALTH INSURANCE; QUALITY ADJUSTED LIFE EXPECTANCY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; REIMBURSEMENT; TAIWAN;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HEALTH EXPENDITURES; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; SMALL CELL LUNG CARCINOMA;

EID: 84889012378     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-579     Document Type: Article

References (35)

1. Guo P, Huang ZL, Yu P, Li K. Trends in cancer mortality in China: an update. Ann Oncol 2012, 23:2755-2762. 10.1093/annonc/mds069, 22492700.
2. Yabroff KR, Bradley CJ, Mariotto AB, Brown ML, Feuer EJ. Estimates and projections of value of life lost from cancer deaths in the United States. J Natl Cancer Inst 2008, 100:1755-1762. 10.1093/jnci/djn383, 2720776, 19066267.
3. Cipriano LE, Romanus D, Earle CC, Neville BA, Halpern EF, Gazelle GS, McMahon PM. Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992-2003. Value Health 2011, 14:41-52. 10.1016/j.jval.2010.10.006, 3150743, 21211485.
4. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes 2005, New York: Oxford University Press, 3.
5. Bravo Vergel Y, Sculpher M. Quality-adjusted life years. Pract Neurol 2008, 8:175-182. 10.1136/pn.2007.140186, 18502950.
6. Institute of Medicine For the Public's Health: The Role of Measurement in Action and Accountability 2011, Washington, D.C.: The National Academies Press, Institute of Medicine.
7. Kutikova L, Bowman L, Chang S, Long SR, Obasaju C, Crown WH. The economic burden of lung cancer and the associated costs of treatment failure in the United States. Lung Cancer 2005, 50:143-154. 10.1016/j.lungcan.2005.06.005, 16112249.
8. Chouaid C, Atsou K, Hejblum G, Vergnenegre A. Economics of treatments for non-small cell lung cancer. Pharmacoeconomics 2009, 27:113-125. 10.2165/00019053-200927020-00003, 19254045.
9. Glasziou PP, Cole BF, Gelber RD, Hilden J, Simes RJ. Quality-adjusted survival analysis with repeated quality of life measures. Stat Med 1998, 17:1215-1229. 10.1002/(SICI)1097-0258(19980615)17:11<1215::AID-SIM844>3.0.CO;2-Y, 9670411.
10. Hwang JS, Tsauo JY, Wang JD. Estimation of expected quality-adjusted survival by cross-sectional survey. Stat Med 1996, 15:93-102. 10.1002/(SICI)1097-0258(19960115)15:1<93::AID-SIM155>3.0.CO;2-2, 8614748.
11. Hwang JS, Wang JD. Integrating health profile with survival for quality of life assessment. Qual Life Res 2004, 13:1-10.
12. ICD-10 Version: 2010. http://apps.who.int/classifications/icd10/browse/2010/en.
13. Hwang JS, Wang JD. Monte Carlo estimation of extrapolation of quality-adjusted survival for follow-up studies. Stat Med 1999, 18:1627-1640. 10.1002/(SICI)1097-0258(19990715)18:13<1627::AID-SIM159>3.0.CO;2-D, 10407234.
14. Fang CT, Chang YY, Hsu HM, Twu SJ, Chen KT, Lin CC, Huang LY, Chen MY, Huang JS, Wang JD, Chuang CY. Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy. Q J M 2007, 100:97-105.
15. Chu PC, Wang JD, Hwang JS, Chang YY. Estimation of life expectancy and the expected years of life lost in patients with major cancers: extrapolation of survival curves under high-censored rates. Value Health 2008, 11:1102-1109. 10.1111/j.1524-4733.2008.00350.x, 18489497.
16. Liu PH, Wang JD, Keating NL. Expected years of life lost for six potentially preventable cancers in the United States. Prev Med 2013, 56:309-313. 10.1016/j.ypmed.2013.02.003, 23428566.
17. Hwang JS. iSQoL: integration of Survival with Quality of Life. http://www.stat.sinica.edu.tw/isqol/.
18. The EuroQol Group EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. The EuroQol Group.
19. Szende A, Oppe M, Devlin N. EQ-5D Value Sets: Inventory, Comparative Review and User Guide 2007, Dodreht, the Netherlands: Springer.
20. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997, 35:1095-1108. 10.1097/00005650-199711000-00002, 9366889.
21. Directorate-General of Budget, Accounting and Statistics, Executive Yuan, R.O.C. (Taiwan). http://eng.dgbas.gov.tw/mp.asp?mp=2.
22. Boyle P, Levin B. World Cancer Report 2008 2008, Geneva: WHO Press.
23. Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS, Field RW, Klotz JB, Letourneau EG, Lynch CF, Lyon JL, Sandler DP, Schoenberg JB, Steck DJ, Stolwijk JA, Weinberg C, Wilcox HB. A combined analysis of North American case-control studies of residential radon and lung cancer. J Toxicol Environ Health A 2006, 69:533-597. 10.1080/15287390500260945, 16608828.
24. Darby S, Hill D, Deo H, Auvinen A, Barros-Dios JM, Baysson H, Bochicchio F, Falk R, Farchi S, Figueiras A, Hakama M, Heid I, Hunter N, Kreienbrock L, Kreuzer M, Lagarde F, Mäkeläinen I, Muirhead C, Oberaigner W, Pershagen G, Ruosteenoja E, Rosario AS, Tirmarche M, Tomásek L, Whitley E, Wichmann HE, Doll R. Residential radon and lung cancer - detailed results of a collaborative analysis of individual data on 7148 persons with lung cancer and 14,208 persons without lung cancer from 13 epidemiologic studies in Europe. Scand J Work Environ Health 2006, 32(Suppl 1):1-83.
25. Ko YC, Lee CH, Chen MJ, Huang CC, Chang WY, Lin HJ, Wang HZ, Chang PY. Risk factors for primary lung cancer among non-smoking women in Taiwan. Int J Epidemiol 1997, 26:24-31. 10.1093/ije/26.1.24, 9126500.
26. Ko YC, Cheng LS, Lee CH, Huang JJ, Huang MS, Kao EL, Wang HZ, Lin HJ. Chinese food cooking and lung cancer in women nonsmokers. Am J Epidemiol 2000, 151:140-147. 10.1093/oxfordjournals.aje.a010181, 10645816.
27. Metayer C, Wang Z, Kleinerman RA, Wang L, Brenner AV, Cui H, Cao J, Lubin JH. Cooking oil fumes and risk of lung cancer in women in rural Gansu, China. Lung Cancer 2002, 35:111-117. 10.1016/S0169-5002(01)00412-3, 11804682.
28. Murthy NS, Nandakumar BS, Pruthvish S, George PS, Mathew A. Disability-adjusted life years for cancer patients in India. Asian Pac J Cancer Prev 2010, 11:633-640.
29. Pham TM, Kubo T, Fujino Y, Ozasa K, Matsuda S, Yoshimura T. Disability-adjusted life years (DALY) for cancer in Japan in 2000. J Epidemiol 2011, 21:309-312. 10.2188/jea.JE20110017, 21628841.
30. Grutters JPC, Joore MA, Wiegman EM, Langendijk JA, de Ruysscher D, Hochstenbag M, Botterweck A, Lambin P, Pijls-Johannesma M. Health-related quality of life in patients surviving non-small cell lung cancer. Thorax 2010, 65:903-907. 10.1136/thx.2010.136390, 20861294.
31. Trippoli S, Vaiani M, Lucioni C, Messori A. Quality of life and utility in patients with non-small cell lung cancer. Pharmacoeconomics 2001, 19:855-863. 10.2165/00019053-200119080-00007, 11596837.
32. Lee LJ, Chung CW, Chang YY, Lee YC, Yang CH, Liou SH, Liu PH, Wang JD. Comparison of the quality of life between patients with non-small-cell lung cancer and healthy controls. Qual Life Res 2011, 20:415-423. 10.1007/s11136-010-9761-y, 20953907.
33. Luo N, Johnson JA, Shaw JW, Feeny D, Coons SJ. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care 2005, 43:1078-1086. 10.1097/01.mlr.0000182493.57090.c1, 16224300.
34. Kahende JW, Woollery TA, Lee CW. Assessing medical expenditures on 4 smoking-related diseases, 1996-2001. Am J Health Behav 2007, 31:602-611. 10.5993/AJHB.31.6.5, 17691873.
35. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011, 103:117-128. 10.1093/jnci/djq495, 3107566, 21228314.